Insider Trading & Ownership - Fox Christine

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Fox Christine
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2025-03-04
Sale
2025-03-06
4:19 pm
TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA Fox Christine
EVP, Head of U.S. Commercial
6,181 $15.8 $97,639 119,768
(Direct)
View
2024-11-20
Sale
2024-11-21
4:04 pm
TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA Fox Christine
EVP, Head of U.S. Commercial
19,388 $16.87 $327,085 234,580
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2025-03-05
Option Award
2025-03-07
4:25 pm
N/A
N/A
TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA Fox Christine
EVP, Head of U.S. Commercial
71,278 $0 71,278
(Direct)
View
2025-03-04
Exercise
2025-03-06
4:19 pm
N/A
N/A
TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA Fox Christine
EVP, Head of U.S. Commercial
20,461 $0 119,768
(Direct)
View
2024-11-20
Exercise
2024-11-21
4:04 pm
N/A
N/A
TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA Fox Christine
EVP, Head of U.S. Commercial
63,492 $0 234,580
(Direct)
View
2024-03-04
Option Award
2024-03-05
4:35 pm
N/A
N/A
TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA Fox Christine
EVP, Head of U.S. Commercial
81,845 $0 81,845
(Direct)
View
2023-11-20
Option Award
2023-11-22
07:18 am
N/A
N/A
TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA Fox Christine
EVP, Head of U.S. Commercial
253,968 $0 253,968
(Direct)
View